Natural Killer Cells: A Review of Biology, Therapeutic Potential and Challenges in Treatment of Solid Tumors
- 14 August 2019
- journal article
- review article
- Published by Taylor & Francis in Future Oncology
- Vol. 15 (26) , 3053-3069
Abstract
Natural killer (NK) cells lead immune surveillance against cancer and early elimination of small tumors. Owing to their ability to engage tumor targets without the need of specific antigen, the therapeutic potential of NK cells has been extensively explored in hematological malignancies. In solid tumors, however, their role in the clinical arena remains poorly exploited despite a broad accumulation of preclinical data. In this article, we review our current knowledge of NK cells' biology, and highlight the challenges facing NK cell antitumor strategies in solid tumors. We further summarize the abundant preclinical attempts at overcoming these challenges, present past and ongoing clinical trial data and finally discuss the potential impact of novel insights on the development of NK cell-based therapies.Keywords
This publication has 136 references indexed in Scilit:
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- Natural killer cells act as rheostats modulating antiviral T cellsNature, 2011
- Spectrum of Cancer Risk Among US Solid Organ Transplant RecipientsJAMA, 2011
- Chemokine nitration prevents intratumoral infiltration of antigen-specific T cellsJournal of Experimental Medicine, 2011
- Age-dependent susceptibility to a viral disease due to decreased natural killer cell numbers and traffickingJournal of Experimental Medicine, 2010
- Hypoxic Tumor Cell Modulates Its Microenvironment to Enhance Angiogenic and Metastatic Potential by Secretion of Proteins and ExosomesMolecular & Cellular Proteomics, 2010
- Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functionsHuman Immunology, 2009
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous MalignancyImmunity, 2008
- HLA alleles determine differences in human natural killer cell responsiveness and potencyProceedings of the National Academy of Sciences, 2008
- Tumor immune escape by the loss of homeostatic chemokine expressionProceedings of the National Academy of Sciences, 2007